The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Sees Large Growth in Short Interest

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totaling 6,216 shares, an increase of 48.3% from the August 31st total of 4,191 shares. Based on an average trading volume of 20,399 shares, the days-to-cover ratio is currently 0.3 days.

Insider Transactions at The Gabelli Healthcare & Wellness Trust

In other The Gabelli Healthcare & Wellness Trust news, major shareholder Saba Capital Management, L.P. bought 4,340 shares of The Gabelli Healthcare & Wellness Trust stock in a transaction on Thursday, August 27th. The stock was purchased at an average cost of $10.05 per share, for a total transaction of $43,617.00. Following the completion of the purchase, the insider directly owned 2,155,133 shares of the company’s stock, valued at $21,659,086.65. The trade was a 0.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders have purchased 38,351 shares of company stock valued at $387,274 in the last ninety days.

Institutional Trading of The Gabelli Healthcare & Wellness Trust

A number of institutional investors and hedge funds have recently made changes to their positions in GRX. Sit Investment Associates Inc. boosted its stake in shares of The Gabelli Healthcare & Wellness Trust by 23.7% during the 4th quarter. Sit Investment Associates Inc. now owns 1,031,350 shares of the investment management company’s stock worth $9,932,000 after acquiring an additional 197,594 shares in the last quarter. Gamco Investors INC. ET AL raised its stake in shares of The Gabelli Healthcare & Wellness Trust by 1.1% in the 1st quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company’s stock valued at $3,132,000 after acquiring an additional 3,800 shares in the last quarter. Aviance Capital Partners LLC raised its stake in shares of The Gabelli Healthcare & Wellness Trust by 2.1% in the 1st quarter. Aviance Capital Partners LLC now owns 171,325 shares of the investment management company’s stock valued at $1,550,000 after acquiring an additional 3,482 shares in the last quarter. Uhlmann Price Securities LLC lifted its holdings in The Gabelli Healthcare & Wellness Trust by 22.0% in the 1st quarter. Uhlmann Price Securities LLC now owns 61,590 shares of the investment management company’s stock worth $557,000 after purchasing an additional 11,088 shares during the last quarter. Finally, Private Advisor Group LLC lifted its holdings in The Gabelli Healthcare & Wellness Trust by 25.2% in the 1st quarter. Private Advisor Group LLC now owns 19,888 shares of the investment management company’s stock worth $180,000 after purchasing an additional 4,000 shares during the last quarter.

The Gabelli Healthcare & Wellness Trust Stock Down 0.7%

Shares of The Gabelli Healthcare & Wellness Trust stock traded down $0.07 during midday trading on Thursday, reaching $9.44. 24,220 shares of the company’s stock traded hands, compared to its average volume of 26,739. The Gabelli Healthcare & Wellness Trust has a 52 week low of $8.80 and a 52 week high of $10.20. The company’s 50 day simple moving average is $9.85 and its 200 day simple moving average is $9.42.

The Gabelli Healthcare & Wellness Trust Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 16th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 7.2%. The ex-dividend date of this dividend was Wednesday, September 16th.

The Gabelli Healthcare & Wellness Trust Company Profile

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a diversified, closed-end investment company focused on long-term growth of capital. Rather than operating healthcare facilities or selling consumer products, the trust invests in publicly traded companies involved in healthcare and wellness.

Its portfolio may include businesses across areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, managed care, diagnostics, consumer health and wellness products, and related industries.